Phase 3 LET Clinical Trials
14 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–14 of 14 trials
Recruiting
Phase 2Phase 3
A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Bristol-Myers Squibb590 enrolled277 locationsNCT07063745
Recruiting
Phase 3
Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children
Musculoskeletal injuryPediatricsSprain and Strain of Ankle+2 more
University of Calgary60 enrolled2 locationsNCT07145645
Recruiting
Phase 3
Canadian Critical Care Comparative Effectiveness Platform
NutritionVasopressorIntensive Care Unit ICU+1 more
Université de Sherbrooke5,500 enrolled8 locationsNCT06605144
Recruiting
Phase 3
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Myocardial Infarction (MI)Cardiovascular EventsPost Polypectomy Bleeding in Antiplatelet Patients
Chinese University of Hong Kong2,514 enrolled1 locationNCT07052799
Recruiting
Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
GliomaAstrocytoma, IDH-Mutant, Grade 2Astrocytoma, Grade IV+5 more
Nuvation Bio Inc.365 enrolled45 locationsNCT05303519
Not Yet Recruiting
Phase 3
Hormone therapy with exercise and education on pain and function in postmenopausal women with subacromial pain syndrome (rotator cuff related shoulder pain). A pilot randomised clinical trial.
Menopause related musculoskeletal painMetabolic derangementTendinopathy
Deakin University60 enrolled1 locationACTRN12626000252314
Recruiting
Phase 3
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
OligodendrogliomaLow-grade Oligodendroglioma1p19q Codeletion
Hospices Civils de Lyon280 enrolled26 locationsNCT04702581
Recruiting
Phase 3
Effects of β-alanine and Sodium Bicarbonate Supplementation on Physical Capacity and Biochemical Markers Concentrations
SupplementationSportsFemale Athletes
Poznan University of Physical Education100 enrolled1 locationNCT07092930
Not Yet Recruiting
Phase 2Phase 3
Safety and Efficacy of FSD202 for the treatment of chronic pain associated with idiopathic MCAS (MCAD)
Chronic Widespread Musculoskeletal Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndrome (Disorder)
FSD Pharma Australia Pty Ltd.60 enrolled1 locationACTRN12625000665437
Recruiting
Phase 3
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
Acute Myeloid Leukemia (AML) in RemissionAcute Lymphoblastic Leukemia (ALL) in Complete Remission
King Faisal Specialist Hospital & Research Center264 enrolled1 locationNCT04314219
Active
Phase 2Phase 3
Efficacy of anti-inflammatory drugs in jaw-joint pain in edentulous patients.
Temporo-mandibular joint painOther muscular or skeletal disorders
Srdjan D. Postic90 enrolled1 locationACTRN12624000434594
Completed
Phase 3
Central venous Access device SeCurement And Dressing Effectiveness in the ICU: the CASCADE ICU Trial
Central venous access device failure prior to completion of therapy
Associate Professor Marion Mitchell120 enrolled1 locationACTRN12615000667516
Not Yet Recruiting
Phase 3
Study for the assessment of clinical non-inferiority and tolerability of Estrogenon (Sanval Comercio e Industria Ltda) in comparasion to Premarin (Wyeth Industria Farmaceutica Ltda) in women post menopause.
Study with the purpose of check clinical non- inferiority and tolerance of conjugated estrogen coated tablet manufactured by different manufacturesWomen in post menopause with indications for estrogens replacement therapy.
Sanval Comercio e Industria Ltda66 enrolled1 locationACTRN12610000119099
Completed
Phase 3
Radiation doses and fractionation schedules in non-low risk Ductal Carcinoma In Situ (DCIS) of the breast.
Completely excised non-low risk DCIS
Trans Tasman Radiation Oncology Group Ltd1,600 enrolled10 locationsACTRN12607000246482